Skip Nav Destination
Issues
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Advances in Brief
Altered Expression of Androgen Receptor in the Malignant Epithelium and Adjacent Stroma Is Associated with Early Relapse in Prostate Cancer1
Susan M. Henshall; David I. Quinn; C. Soon Lee; Darren R. Head; David Golovsky; Phillip C. Brenner; Warick Delprado; Phillip D. Stricker; John J. Grygiel; Robert L. Sutherland
Absence of Endothelial Cells, Central Necrosis, and Fibrosis Are Associated with Aggressive Inflammatory Breast Cancer1
Kazuo Shirakawa; Hitoshi Tsuda; Yuji Heike; Kazunori Kato; Rumiko Asada; Motoko Inomata; Hiroki Sasaki; Fujio Kasumi; Masataka Yoshimoto; Toshihiko Iwanaga; Fumio Konishi; Masaaki Terada; Hiro Wakasugi
RB2/p130 Gene-enhanced Expression Down-Regulates Vascular Endothelial Growth Factor Expression and Inhibits Angiogenesis in Vivo1
Pier Paolo Claudio; Peter Stiegler; Candace M. Howard; Cristiana Bellan; Corrado Minimo; Gian Marco Tosi; Janusz Rak; Al Kovatich; Paola De Fazio; Pietro Micheli; Mario Caputi; Lorenzo Leoncini; Robert Kerbel; Giovan Giacomo Giordano; Antonio Giordano
15S-Hydroxyeicosatetraenoic Acid Activates Peroxisome Proliferator-activated Receptor γ and Inhibits Proliferation in PC3 Prostate Carcinoma Cells1
Scott B. Shappell; Rajnish A. Gupta; Suzanne Manning; Robert Whitehead; William E. Boeglin; Claus Schneider; Tom Case; James Price; Gregory S. Jack; Thomas M. Wheeler; Robert J. Matusik; Alan R. Brash; Raymond N. DuBois
Tumor Biology
Direct Evidence of the Importance of Stromal Urokinase Plasminogen Activator (uPA) in the Growth of an Experimental Human Breast Cancer Using a Combined uPA Gene-Disrupted and Immunodeficient Xenograft Model
Thomas Leth Frandsen; Claus Holst-Hansen; Boye Schnack Nielsen; Ib Jarle Christensen; Jens R. Nyengaard; Peter Carmeliet; Nils Brünner
Deregulated Expression of c-mos in Non-Small Cell Lung Carcinomas: Relationship with p53 Status, Genomic Instability, and Tumor Kinetics
Vassilis G. Gorgoulis; Panayotis Zacharatos; George Mariatos; Triantafillos Liloglou; Stavros Kokotas; Nikolaos Kastrinakis; Athanassios Kotsinas; Athanassios Athanasiou; Pericles Foukas; Vassilios Zoumpourlis; Dimitris Kletsas; John Ikonomopoulos; Panayiotis J. Asimacopoulos; Christos Kittas; John K. Field
Targeted Inactivation of the p21WAF1/cip1 Gene Enhances Apc-initiated Tumor Formation and the Tumor-promoting Activity of a Western-Style High-Risk Diet by Altering Cell Maturation in the Intestinal Mucosa1
Wan Cai Yang; Joseph Mathew; Anna Velcich; Winfried Edelmann; Raju Kucherlapati; Martin Lipkin; Kan Yang; Leonard H. Augenlicht
Carcinogenesis
Endocrinology
Immunology
Molecular Biology and Genetics
Cyclin E is the Only Cyclin-dependent Kinase 2-associated Cyclin that Predicts Metastasis and Survival in Early Stage Non-Small Cell Lung Cancer1
Carsten Müller-Tidow; Ralf Metzger; Katrin Kügler; Sven Diederichs; Gregory Idos; Michael Thomas; Barbara Dockhorn-Dworniczak; Paul M. Schneider; H. Phillip Koeffler; Wolfgang E. Berdel; Hubert Serve
Experimental Therapeutics
The HER Tyrosine Kinase Inhibitor CI1033 Enhances Cytotoxicity of 7-Ethyl-10-hydroxycamptothecin and Topotecan by Inhibiting Breast Cancer Resistance Protein-mediated Drug Efflux1
Charles Erlichman; Scott A. Boerner; Christopher G. Hallgren; Rebecca Spieker; Xiao-Yang Wang; C. David James; George L. Scheffer; Marc Maliepaard; Douglas D. Ross; Keith C. Bible; Scott H. Kaufmann
Pretreatment with Paclitaxel Enhances Apo-2 Ligand/Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis of Prostate Cancer Cells by Inducing Death Receptors 4 and 5 Protein Levels
Ramadevi Nimmanapalli; Charles L. Perkins; Marianagelli Orlando; Erica O’Bryan; Diep Nguyen; Kapil N. Bhalla
Epidemiology
Correction
Advertisement